← Evidence map

ArticleClinical kidney journal2025

Efficacy and safety of belimumab in refractory and newly diagnosed active lupus nephritis patients: a real-world observational study.

Ying Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40416394